Briacell Therapeutics Corp (BCT.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 07/31
| 07-2024 | 04-2024 | 01-2024 | 10-2023 | 07-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 862 | 936 | 6,245 | 13,646 | 21,251 |
| Receivables | 1,369 | 15 | 30 | 21 | 19 |
| TOTAL | $3,654 | $5,530 | $11,742 | $18,408 | $26,949 |
| Non-Current Assets | |||||
| PPE Net | 388 | N/A | N/A | N/A | N/A |
| Investments And Advances | 418 | 470 | 282 | 0 | 0 |
| Intangibles | 200 | 204 | 207 | 211 | 215 |
| Other Non-Current Assets | 1,212 | 0 | 0 | 0 | 0 |
| TOTAL | $2,218 | $673 | $489 | $211 | $215 |
| Total Assets | $5,872 | $6,203 | $12,231 | $18,619 | $27,164 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 7,171 | 6,422 | 3,711 | 434 | 1,124 |
| Accrued Expenses | 290 | 335 | 213 | 613 | 678 |
| TOTAL | $7,461 | $6,758 | $3,924 | $1,047 | $1,801 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 1,399 | 5,946 | 16,869 | 15,262 | 29,139 |
| TOTAL | $1,096 | $5,679 | $16,624 | $15,056 | $29,139 |
| Total Liabilities | $8,557 | $12,436 | $20,549 | $16,103 | $30,941 |
| Shareholders' Equity | |||||
| Common Shares | 72,166 | 69,592 | 69,592 | 69,592 | 69,592 |
| Retained earnings | -85,444 | -84,230 | -85,945 | -74,651 | -80,652 |
| Other shareholders' equity | 10,895 | 8,673 | 8,280 | -139 | -139 |
| TOTAL | $-2,382 | $-5,965 | $-8,073 | $2,721 | $-3,777 |
| Total Liabilities And Equity | $6,175 | $6,471 | $12,475 | $18,824 | $27,164 |